Purpose: Many stroke patients with large vessel occlusion present with a low National Institutes of Health Stroke Scale (NIHSS). There is currently no level 1A recommendation for endovascular treatment (EVT) for this patient subgroup. From a physician's standpoint, the deficits might only be slight, but they are often devastating from a patient perspective. Furthermore, early neurologic deterioration is common. The purpose of this study was to explore endovascular treatment attitudes of physicians in acute ischemic stroke patients presenting with low admission NIHSS. Methods: In an international cross-sectional survey among stroke physicians, participants were presented the scenario of a 76-year-old stroke patient with an admission NIHSS ...
Context: Despite overwhelming evidence for endovascular therapy in anterior circulation ischemic str...
Background: Understanding how many patients are eligible for endovascular therapy can help develop m...
BACKGROUND AND PURPOSE: Clinical trials are assessing the efficacy of fibrinolysis in extended time ...
BACKGROUND Current stroke treatment guidelines restrict level 1A recommendations for endovascular...
Background: Evidence for efficacy and safety in stroke patients ≥80 years is limited, since they wer...
Background: It is unclear what factors clinicians consider when deciding about endovascular thrombec...
BACKGROUND: With the increasing age of acute stroke patients being admitted to hospitals, more data ...
International audienceBACKGROUND: Whether endovascular therapy (EVT) added on best medical managemen...
BACKGROUND Since 2015, endovascular therapy has been established as a standard of care for acute ...
Background and Purpose- Little is known about the real-life factors that clinicians use in selection...
Background and Purpose- Little is known about the real-life factors that clinicians use in selection...
BACKGROUND: Recent studies have demonstrated the superiority of endovascular therapy (EVT) for emerg...
With the increasing age of acute stroke patients being admitted to hospitals, more data are needed o...
International audienceBackground and Purpose: Although the efficacy of endovascular treatment (EVT) ...
Background and Purpose-We assessed the effect of endovascular treatment in acute ischemic stroke pat...
Context: Despite overwhelming evidence for endovascular therapy in anterior circulation ischemic str...
Background: Understanding how many patients are eligible for endovascular therapy can help develop m...
BACKGROUND AND PURPOSE: Clinical trials are assessing the efficacy of fibrinolysis in extended time ...
BACKGROUND Current stroke treatment guidelines restrict level 1A recommendations for endovascular...
Background: Evidence for efficacy and safety in stroke patients ≥80 years is limited, since they wer...
Background: It is unclear what factors clinicians consider when deciding about endovascular thrombec...
BACKGROUND: With the increasing age of acute stroke patients being admitted to hospitals, more data ...
International audienceBACKGROUND: Whether endovascular therapy (EVT) added on best medical managemen...
BACKGROUND Since 2015, endovascular therapy has been established as a standard of care for acute ...
Background and Purpose- Little is known about the real-life factors that clinicians use in selection...
Background and Purpose- Little is known about the real-life factors that clinicians use in selection...
BACKGROUND: Recent studies have demonstrated the superiority of endovascular therapy (EVT) for emerg...
With the increasing age of acute stroke patients being admitted to hospitals, more data are needed o...
International audienceBackground and Purpose: Although the efficacy of endovascular treatment (EVT) ...
Background and Purpose-We assessed the effect of endovascular treatment in acute ischemic stroke pat...
Context: Despite overwhelming evidence for endovascular therapy in anterior circulation ischemic str...
Background: Understanding how many patients are eligible for endovascular therapy can help develop m...
BACKGROUND AND PURPOSE: Clinical trials are assessing the efficacy of fibrinolysis in extended time ...